Artemisinin Resistance – threats and responses

Artemisinin Resistance – threats and responses
Date: Thursday 24 April 2014  17:00 – 19:00 pm
Location: John Snow Lecture Theatre, LSHTM, Keppel Street, London, WC1E 7HT
One of the mainstays of recent successes in malaria control has been the effective deployment of artemisinin-based combination therapy (ACT) in malaria endemic countries worldwide. As with antimalarial treatments used in the past, ACT are under threat from the development of resistance by the malaria parasite Plasmodium falciparum.
Speakers include:  
Dr Colin Sutherland (LSHTM Malaria Reference Laboratory);  
Dr Christian Nsanzabana (WWARN); 
Prof Chris Drakeley (LSHTM Malaria Centre)
; Prof Nick WHITE (Mahidol-Oxford Research Unit, Bangkok)
; 
Dr Sylvia Meek (Malaria Consortium)
; and 
Prof. David Schellenberg – Chair (LSHTM ACT Consortium)